Leading innovative devices for acoustic
cell processing
We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Trusted by
Aenitis Technologies aims to become a world leader in cells handling solutions by acoustophoresis.
Who we are
Cell Therapy: The New Biotech Gold Rush
Aenitis Technologies is a French spin off ESPCI ParisTech, a research engineer’s school in Paris and The National Center for Scientific Research (CNRS).

Aenitis Technologies is developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies.

Our first focuse is on technological solutions that will revolutionize current practices in Public Health by improving bioproduction processing in cell therapy areas
2014
Year founded
9M€
Money Raised
14
Patents families
How did we started?
Aenitis' Journey
Since 2015
2015
€1.7M Raised
French Ministry of Research and Paris Region mail innovation concourses awards - €700k grants

Seventure Partners - €1M Capital Increase
End: 6m before deadline
2017
€4M Raised
Lab prototype on Labile blood product validated on human blood

Platelets journal publication: world first on platelets processing without activation

H2020 European Commission program recognition
End: 6m before deadline
2018
€2.1M Raised
1st acoustofluidic disposable injected alpha prototypes delivered

1st device - machine - alpha prototype delivered

Weaving Invest & Seventure Partners - €1M capital increase

France Innovation Concours winner on Islets acoustic sorting - €1.1M grants

Winner of European Commission EIT Health MedTech Catapult concours
End: 6m before deadline
2019
€1M Raised
End of feasibility for the acoustic platelets processing. Launch of the industrialization.

€1M grant on Mesenchymal Stem Cell Acoustic Sorter, supported by the French Ministry of Economic and the French Ministry of the Army.

Key Partnership with a large corporate
End: 6m before deadline
2020
€500k Raised + 600k COVID support free loan
Acoustic Blood Cell sorter industrialization

€500k grant acoustic Transduction and transfection boost system, supported by Paris Region.

ISO 13485 engaged
End: 6m before deadline
2021
€1.7M Raised
End: 6m before deadline
Key production lines and partnerships identified and contractualised

Grant support industrialization for Europe resilience supported by French government and European fundings

Grant to for acoustic transduction and transfection with Yposkesi, INSERM and CNRS, supported by French government.

Development of a lab instrument for any non-clinical use called the Cube
2022
€4M Fundraising planed
End: 6m before deadline
Launch of final in vitro and in real conditions tests

Submission of the file for CE marking of ABC-S devices and disposables

Launch of final industrial production

CE marking of the Cube and 1st sales
2022 / 2024 Vision
Our aim is to become a world leader in cell therapy processing devices solutions based on acoustophoresis.
$19.9Bn
is the Global cell therapy processing devices market
expected for 2023 according to (MarketsAndMarkets)
CAGR 14,4%
Aenitis' acoustophoretic approach enable to simplify Bioprocess in cell therapies, aiming:

- yield increase,
- more secure processing,
- lower cost processing ,
- and higher cell quality.

Today, for example, Aenitis' approach permits on platelet processing to gain, compared to current standards, 15% on platelets recovery, 20% on the processing timing, reduce handling contain and reduce costs. Platelets are also not activated by acoustic handling that permit optimal quality to be maintained.
Our team
Our strength is in our team

After obtaining a Master in Cellular and Molecular Biology from the University of Nantes (FR) and the University of Sussex (UK), Emmanuel completed his training with a Specialized Master in Management of Biotechnology Companies in Grenoble Ecole de Management (Grenoble Business School). He also holds an Executive Master of Business and Administration (eMBA) from the University Paris-Dauphine (FR) and the University of Quebec in Montreal (CA). Emmanuel has a strong professional experience in international business development, in analysis of business models and in consolidation of strategic intelligence in the biotechnology sector. He also has a good knowledge of the biotech ecosystem in France, and of the major world bioclusters.

Emmanuel VINCENT
Co-founder and Chief Executive Officer
Linkedin

Jacky holds a degree of the DESF (Graduate degree in accounting and financial studies) and began his career in an audit and financial expertise firm during 4 years. For nearly 20 years, Jacky holds positions in Finance (CFO) and General Management (COO/CEO) in companies with high development potential (Startups).
The quality of the relations that Jacky has forged with his investors, led him in addition to advising them to regularly represent them on the management and/or strategic committees of other companies that they finance.
His experience and analytical skills allow him to combine the management of day-to-day imperatives with the medium- and long-term objectives of a company with high development potential.

Jacky HARROUET
Chief Financial Officer
Linkedin

Skander holds a Master's degree in mechanical engineering from Arts & Métiers ParisTech.
Skander worked in the aerospace industry for 12 years, holding quality, continuous improvement and production management roles. Just before joining Aenitis, he worked for 3 years at Pall Life Science on the development and industrialization of Single-Use components for biotechnological applications.

Skander ROLLET
Chef Development & Production Officer
Linkedin

Coming from the field of Applied Physics, Jérémie Gachelin holds a Master’s degree in Complex Systems (Denis Diderot University, Paris). After a PhD in Physics, he worked for three years in the PMMH laboratory in Paris and the Departemento de Physica at the Universidad de Chile on an experimental and digital study of the interactions between micro-swimmers (i.e. E. Coli bacteria). This study included the analysis from a physicist point of view of the effects of the presence of a surrounding flow using microfluidic devices. Jérémie has therefore developed expertise in microfluidics, microbiology, and digital simulations for applications in physics.

Jérémie GACHELIN
Biophysics Engineer - PhD
Linkedin

Azita received her PhD in Mechanobiology from the National University of Singapore. During her PhD she showed the synergistic effect of a tyrosine phosphatase inhibitor and substrate topography on Endothelial cell behavior. After her PhD she joined a lab in Paris at Institut Pierre-Gilles de Gennes, for her postdoctoral research. She explored the effect of mechanical cues on the cancer cell using a microfluidic system mimicking the microvasculature. She as well took the role of project manager at INSERM and participated in clinical trial projects and grant writing. Azita has an intense experience in the field of molecular biology and biotechnology. Azita is in charge of all biological controls and protocols on Aenitis developments.

Azita GORJI
Senior Biology Engineer - PhD
Linkedin

Nicolas earned both a master's and PhD degree from the University of Bordeaux, France in acoustics, laser, and fluid mechanics, more specifically working on the effects of radiation pressure on liquid interfaces. He designed experiments as well as developed a new theory on the self-guiding of acoustic waves in liquids. He then joined the Complex Fluids team at the University of Melbourne, Australia for a post-doctoral fellowship on polymers and particles in shear-flow, broadening his skills in experimental soft matter and 3D printing. 2 years later, he joined the BubbleBoost project at the Laboratoire Interdisciplinaire de Physique in Grenoble, France, working for 3 years on generating flows with acoustically-driven microbubbles. This project made use of his expertise in acoustofluidics and 3D printing, applying them to microfluidic applications. It led him to collaborate fruitfully with theorists, chemists and engineers.

Nicolas BERTIN
Biophysics Engineer - PhD
Linkedin

After a master’s degree in Quality & Control at Cergy-Pontoise University, Youssra worked as a Supplier Quality Manager at Hutchinson for 1 year, then she joined Virbac where she worked as a Quality Assurance Manager. Her different positions allowed her to occur strong skills in Quality and in Regulatory Affairs. Now, Youssra is in charge of Regulatory affairs and Quality System implementation at Aenitis.

Youssra ZEGRARI
Regulatory Affairs and Quality Engineer
Linkedin

After a master's degree in 3D engineering and video games, Valentin worked in eye analysis devices and softwares for 4 years then, he joined Kickmaker where he worked on various subjects from autonomous cars to massive events like the League of legends world cup.Valentin lead softwares development at Aenitis.

Valentin HAYOT
Lead Developer full stack
Linkedin
-
Strategic Advisory Board

Philippe Tramoy earned degrees in Biochemistry (MSc) and Genetics & Immunology (MSc) from the University of Burgundy and from the Ecole Normale Supérieure Lyon and later graduated from the IAE Paris Pantheon-Sorbonne (Master of Finance) and HEC Paris (Master in Marketing). Philippe’s responsibilities have been wide-ranging and included being Project Manager and Business Development Manager in Europe and Israel on the biotechnology market at Rhodia Corporate, Rhodia Chirex, and Rhodia Pharma Solutions.
In 2004, he founded and managed a market and business intelligence company with offices in France, Switzerland and Israel : CBDMT – Market & Business Intelligence. During his career, Philippe developed an extensive network of contacts and core competences including business development, strategy, marketing and finance. Philippe joined Seventure in November 2013. He is a Partner at the Life sciences investments of Quadrivium 1.

Philip TRAMOY
Strategic Board Member
Linkedin

Cofounder and previous CEO of Ovizio Imaging Systems, Philip is a success entrepreneur with good knowledge of Cell therapy markets and start-up development issues.
Passionate about science and technology, Philip holds an engineering degree in electronics and telecommunications and started his career in the high-tech sector where he held management positions for large companies in several European countries, developing strong business and commercial skills, completed by an MBA from ESCP, Paris. Throughout his career, Philip has always been driven by a will to transform his technological, market and financial knowledge in sellable and innovative products, services and solutions. After 10 years in corporate environments, Philip decided to follow the entrepreneurial path and launched his biggest professional challenges starting his first ventures.

Philip MATHUIS
Strategic Board Member
Linkedin

After graduating from the Albi Carmaux School of Mining Engineering, Idir Idjerouidene held the positions of COO and member of the board of the company Aigle Azur. Since 2011, Idir Idjerouidene is Managing Director of the Weaving Group Investment Fund.

Idir IDJEROUIDENE
Strategic Board Member
Linkedin

CNRS Research Director at the Laboratory of Physics and Mechanics of Heterogeneous Environments (PMMH), UMR7636 CNRS, and at ESPCI, Jean-Luc is a specialist in fluid mechanics and flow control. Jean-Luc worked for 7 years in the Aerodynamics research unit of the Research and Innovation Department of PSA Peugeot-Citroën as the head of a research and innovation project. He joined the CNRS in October 2005 where he developed research programs in the field of flow control, external aerodynamic instabilities, and transition to turbulence and micro-flows. Jean-Luc demonstrated the potential of the acoustic manipulation of particles for metrological applications (micro-PIV). Jean-Luc also discovered that acoustic streaming in micro-channels can be used beyond the conventional resonance condition in order to create a "sound tweezer" that enables the fine handling of species in suspension.

Jean-Luc AIDER
Co-founder, President of Scientific Advisory Board
Linkedin

After obtaining a Master in Cellular and Molecular Biology from the University of Nantes (FR) and the University of Sussex (UK), Emmanuel completed his training with a Specialized Master in Management of Biotechnology Companies in Grenoble Ecole de Management (Grenoble Business School). He also holds an Executive Master of Business and Administration (eMBA) from the University Paris-Dauphine (FR) and the University of Quebec in Montreal (CA). Emmanuel has a strong professional experience in international business development, in analysis of business models and in consolidation of strategic intelligence in the biotechnology sector. He also has a good knowledge of the biotech ecosystem in France, and of the major world bioclusters.

Emmanuel VINCENT
Strategic Board Member
Linkedin
-
Scientific Advisory Board

Miguel Lozano, MD, PhD is Hematologist. He is currently Hemotherapy Section Head at the department of Hemotherapy and Hemostasis of the Clínic University Hospital, and Associate Professor of Medicine at the University of Barcelona, in Barcelona, Spain. He is also President of the European Society for Hemapheresis, European Regional Director of the ISBT Board and chair of the AABB Press Editorial Board. He has been scientific member of BEST Collaborative since 2002. He is the author or co-author of over 200 papers, monographs and book chapters dealing with topics related with Transfusion Medicine and Hemostasis. He has co-edited books for AABB Press about Globalization in Transfusion Medicine, Blood Component Preparation and Platelet Transfusion Therapy.

Dr. Miquel LOZANO
Scientific Advisory Board Member
Linkedin

INSERM research director at the Langevin Institute ESPCI Paris, Mickaël developed with his team new therapy techniques and medical imaging, including, for example, non-invasive treatment of brain disorders with transcranial focused ultrasound (Equipex Ultrabrain) or a new brain imaging technique: the"fUltrasound" (functional brain Ultrasound). This imaging technique based on the study of blood flow can detect changes in cerebral activity. His works led to the creation of a French company, Supersonic Imagine, which markets a scanner that can distinguish the tissue elasticity and variations and identify cancerous tumors. He also founded in 2015 Cardiawave that develops a revolutionary non-invasive medical device to treat a heart condition calledaortic stenosis. Mickaël Tanter is a member of the scientific council of the Ile de France, deputy director of the Langevin Institute, winner of Equipex with his team. He won the grand prize of Medical Research Jean Hamburger of the city of Paris in 2012, co-winner with Mathias Fink, Jacques Souquet and Jeremy Bercoff the Yves Rocard Prize the French Society of Physics 2011, winner of the Léon Brillouin the electricity Company, electronics and information and communications technology (EES) and the Institute of electrical and electronics Engineers (IEEE) in 2010, Montgolfier Prize winner of the Corporation encouragement for the domestic industry in 2010.

Mickaël TANTER
Scientific Advisory Board Member
Linkedin

Chaouqi is an exceptional category CNRS research director at the Interdisciplinary Physics laboratory of Joseph FOURNIER University in Grenoble (France). Chaouqi developed over the year a world expertise on complex fluids with a large focus on blood in vivo and in microchannels (over 200 publications and books).

Chaouqi MISBAH
Scientific Advisory Board Member
Linkedin

CNRS Researcher at the Laboratory of Physics and Mechanics of Heterogeneous Environments (PMMH), UMR7636 CNRS, and at ESPCI, Mauricio is a specialist in dispersed colloidal environments, in separation sciences and in ultrasounds. Mauricio is the Winner 2014 of the Henri-Langlois price for the quality of his work in the PMMH Laboratory. Mauricio worked for more than 20 years in the field of technical separation of polymer particles and blood cells using force fields (centrifugal, thermal and magnetic). He has been developing ultrasonic separation technologies for biological applications for many years.

Mauricio HOYOS
Co-founder, Scientific Advisory Board Member
Linkedin

CNRS Research Director at the Laboratory of Physics and Mechanics of Heterogeneous Environments (PMMH), UMR7636 CNRS, and at ESPCI, Jean-Luc is a specialist in fluid mechanics and flow control. Jean-Luc worked for 7 years in the Aerodynamics research unit of the Research and Innovation Department of PSA Peugeot-Citroën as the head of a research and innovation project. He joined the CNRS in October 2005 where he developed research programs in the field of flow control, external aerodynamic instabilities, and transition to turbulence and micro-flows. Jean-Luc demonstrated the potential of the acoustic manipulation of particles for metrological applications (micro-PIV). Jean-Luc also discovered that acoustic streaming in micro-channels can be used beyond the conventional resonance condition in order to create a "sound tweezer" that enables the fine handling of species in suspension.

Jean-Luc AIDER
Co-founder, President of Scientific Advisory Board
Linkedin

Nobis voluptates aperiam excepturi doloribus rem unde in. Autem aspernatur veniam ab temporibus. Voluptatem odit at quaerat adipisci tenetur omnis. Eveniet qui distinctio excepturi est et necessitatibus. Qui saepe voluptas exercitationem nam quo error commodi ducimus possimu

Aut Quaerat Qui Officiis
Linkedin
Test team Member

Nemo quos suscipit. Enim nihil suscipit quisquam et et. Ipsum repellat consequatur rerum voluptatem. Ex consectetur non tempora praesentium omnis ipsam. Perspiciatis id odit doloremque. Enim tempore id cum ducimus odio dolorum accusamus dolore. Aut dolores

Dolor Eaque Sequi Nihil
Linkedin
Test team Member

Vitae reiciendis odit eum dolor. Sunt sed aperiam dicta ullam aut explicabo molestiae ut. Quaerat aliquam ad. Culpa autem modi voluptatem suscipit modi sit odit ullam adipisci. Provident sed quis quis autem ex tenetur. Ut deserunt ipsum ea ex hic. Perferendis et adipisci modi maiore

Soluta Autem
Linkedin
Test team Member

Cupiditate et quo et dolor aut assumenda possimus. Mollitia quisquam eius dolor consequuntur quia qui et et laborum. Est magni qui quisquam rem tempore. Id quae q

Architecto Vero
Linkedin
Test team Member

Nostrum non quia consequatur sunt beatae expedita eligendi fugiat qui. Officia deleniti omnis repudiandae omnis repudiandae esse dolor iure. Consectetur accusantium totam omnis itaque dolor modi odit placeat. Sunt qui reprehenderit aut accusantium quisquam assumenda. Ut eaque aut

Tempore Ut
Linkedin
Test team Member
Latest News
Be up to date with Aenitis technology
May 30, 2023
Event on Acoustic Cell Handling
Read More
October 22, 2021
Annonce des premiers lauréats de l’appel à manifestation d’intérêt (AMI) et de l'appel à projets (AAP) « Grand defi biomédicament »
Read More
December 12, 2019
Aenitis sur le congres polepharma bioproduction 2019
Read More
November 28, 2019
"Fervently driving disruptive innovation in healthcare", Insightcare, October 2019
Read More
November 23, 2019
Eit health summit event in Paris on DEC 2ND & 3RD 2019
Read More
November 22, 2019
Bio Europe 2019 in Hamburg
Read More
November 8, 2019
Aenitis technologies on bio Europe, Hamburg, Germany
Read More
February 15, 2019
Start-up & Innovation: Aenitis Technologies Laureate Of The Ftti 2019 And Finalist Of The Evc 2019!
Read More
December 20, 2018
Second Semester Of 2018
Read More
December 19, 2018
Winner Of The Innovation Contest, Aenitis Technologies Receives 1,1m€
Read More
December 6, 2018
Aenitis technologies has been awarded the 1st prize in the European eit health catapult
Read More
November 30, 2017
Aenitis technologies receives €4 million in funding from the european H2020 sme instrument programme, for its abc-s’ project
Read More
October 19, 2016
French public institutions cnrs, espci and upmc establish a stake in aenitis technologies via fist sa, the cnrs’ technology expl
Read More
July 4, 2015
Aenitis Technologies ​: Winner of 17th Contest in Category I-lab Creation Development
Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.